Quoting Michail Ignatiadis, Jules Bordet Institute, on Twitter:
“Join us tomorrow with Peter Fasching, Sara Tolaney and Stephen Johnston to discuss QoL in the phase 3 NATALEE trial of adjuvant ribociclib, ESMO Virtual Plenary with AACR Expert Commentary: September 2023″
For details click here.
Source: Michail Ignatiadis/Twitter